RIGL (STOCKS)
Rigel Pharmaceuticals Inc. (New)
$29.970000
+0.770000 (+2.64%)
Prev close: $29.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raul R. Rodriguez
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $553.64M
- Employees
- 164
- P/E (TTM)
- 1.50
- P/B (TTM)
- 1.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.15 | $1.27 | -0.1217 | -9.57% |
|
Sep 2025 (Q3)
|
$1.46 | $0.87 | +0.5882 | +67.47% |
|
Jun 2025 (Q2)
|
$3.28 | $2.63 | +0.6484 | +24.64% |
|
Mar 2025 (Q1)
|
$0.63 | $0.09 | +0.5390 | +592.31% |
Financial Statements
| Revenues | $294.28M |
| Benefits Costs and Expenses | $172.46M |
| Cost Of Revenue | $19.62M |
| Costs And Expenses | $168.82M |
| Gross Profit | $274.66M |
| Operating Expenses | $149.20M |
| Selling, General, and Administrative Expenses | $115.90M |
| Research and Development | $33.30M |
| Operating Income/Loss | $125.47M |
| Income/Loss From Continuing Operations After Tax | $367.02M |
| Income/Loss From Continuing Operations Before Tax | $121.83M |
| Income Tax Expense/Benefit | -$245.20M |
| Income Tax Expense/Benefit, Current | $655.00K |
| Income Tax Expense/Benefit, Deferred | -$245.85M |
| Net Income/Loss | $367.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $367.02M |
| Net Income/Loss Available To Common Stockholders, Basic | $367.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $20.40 |
| Diluted Earnings Per Share | $19.48 |
| Basic Average Shares | 17,987,000 |
| Diluted Average Shares | 18,840,000 |
| Assets | $513.59M |
| Current Assets | $240.17M |
| Cash | $155.00M |
| Inventory | $11.51M |
| Other Current Assets | $73.66M |
| Noncurrent Assets | $273.43M |
| Fixed Assets | $30.00K |
| Other Non-current Assets | $273.40M |
| Liabilities | $122.11M |
| Current Liabilities | $99.24M |
| Accounts Payable | $7.19M |
| Wages | $11.91M |
| Other Current Liabilities | $80.13M |
| Noncurrent Liabilities | $22.88M |
| Long-term Debt | $52.50M |
| Equity | $391.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $391.48M |
| Liabilities And Equity | $513.59M |
| Net Cash Flow From Operating Activities | $75.66M |
| Net Cash Flow From Operating Activities, Continuing | $75.66M |
| Net Cash Flow From Investing Activities | -$92.37M |
| Net Cash Flow From Investing Activities, Continuing | -$92.37M |
| Net Cash Flow From Financing Activities | $601.00K |
| Net Cash Flow From Financing Activities, Continuing | $601.00K |
| Net Cash Flow | -$16.11M |
| Net Cash Flow, Continuing | -$16.11M |
| Comprehensive Income/Loss | $367.20M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $367.20M |
| Other Comprehensive Income/Loss | $171.00K |